Skip to main content

Advertisement

SpringerLink
Log in

RETRACTED ARTICLE: Evidence for involvement of steroid receptors and coactivators in neuroepithelial and meningothelial tumors

  • Research Article
  • Published:
Tumor Biology

This article was retracted on 20 April 2017

Abstract

Steroid receptors such as androgen receptor (AR) and estrogen receptors (ER) ER-α and ER-β, and their receptor coactivators (steroid receptor coactivator, SRC) are widely localized in the brain. Although previous studies have investigated the expression of steroid receptors in brain tumors like astrocytoma, the studies on the expression of steroid receptors and SRCs in other brain tumors are lacking. Here, we investigated the expression of AR, ERs, and SRCs in neuroepithelial (medulloblastoma, ependymoma, oligodendroglioma) and meningothelial meningioma using tissue microarray immunohistochemistry. Compared to normal brain tissue, we found that the expression of SRC-1, SRC-3, and ER-α significantly decreased in meningothelial tumor and neuroepithelial tumor, suggesting that the SRC-1/SRC-3 levels may be regulated by ER-α. Moreover, the levels of AR strongly correlated to the levels of ER-β. Furthermore, correlation was also detected between SRC-3 and AR in neuroepithelial tumor, and between ER-α and ER-β in meningothelial tumor. In addition, the decreased ratio of SRC-1/SRC-3 was associated with an increase of ER-β in neuroepithelial tumor. These results indicate that expressions of different steroid receptors and activators may be tumor type dependent. While AR, ER-α, and ER-β may be involved in the pathogenesis of meningothelial tumor, SRCs/ER-β axis and SRC-3/AR axis may play a role in the pathogenesis of neuroepithelial tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Vest RS, Pike CJ. Gender, sex steroid hormones, and Alzheimer’s disease. Horm Behav. 2013;63(2):301–7.

    Article  CAS  PubMed  Google Scholar 

  2. Baudry M, Bi X, Aguirre C. Progesterone-estrogen interactions in synaptic plasticity and neuroprotection. Neuroscience. 2013;239:280–94.

    Article  CAS  PubMed  Google Scholar 

  3. Zhang JQ, Cai WQ, Zhou DS, Su BY. Distribution and differences of estrogen receptor beta immunoreactivity in the brain of adult male and female rats. Brain Res. 2002;935(1–2):73–80.

    Article  CAS  PubMed  Google Scholar 

  4. Fernandez-Guasti A, Kruijver FP, Fodor M, Swaab DF. Sex differences in the distribution of androgen receptors in the human hypothalamus. J Comp Neurol. 2000;425(3):422–35.

    Article  CAS  PubMed  Google Scholar 

  5. Kruijver FP, Fernandez-Guasti A, Fodor M, Kraan EM, Swaab DF. Sex differences in androgen receptors of the human mamillary bodies are related to endocrine status rather than to sexual orientation or transsexuality. J Clin Endocrinol Metab. 2001;86(2):818–27.

    Article  CAS  PubMed  Google Scholar 

  6. Liu F, Day M, Muniz LC, Bitran D, Arias R, Revilla-Sanchez R, et al. Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory. Nat Neurosci. 2008;11(3):334–43.

    Article  CAS  PubMed  Google Scholar 

  7. Bean LA, Ianov L, Foster TC. Estrogen receptors, the hippocampus, and memory. Neuroscientist. 2014.

  8. Clipperton-Allen AE, Lee AW, Reyes A, Devidze N, Phan A, Pfaff DW, et al. Oxytocin, vasopressin and estrogen receptor gene expression in relation to social recognition in female mice. Physiol Behav. 2012;105(4):915–24.

    Article  CAS  PubMed  Google Scholar 

  9. Jones BA, Watson NV. Spatial memory performance in androgen insensitive male rats. Physiol Behav. 2005;85(2):135–41.

    Article  CAS  PubMed  Google Scholar 

  10. Cowppli-Bony A, Bouvier G, Rue M, Loiseau H, Vital A, Lebailly P, et al. Brain tumors and hormonal factors: review of the epidemiological literature. Cancer Causes Control. 2011;22(5):697–714.

    Article  PubMed  Google Scholar 

  11. Chung YG, Kim HK, Lee HK, Lee KC. Expression of androgen receptors in astrocytoma. J Korean Med Sci. 1996;11(6):517–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Carroll RS, Zhang J, Dashner K, Sar M, Black PM. Steroid hormone receptors in astrocytic neoplasms. Neurosurgery. 1995;37(3):496–503. discussion 503–494.

    Article  CAS  PubMed  Google Scholar 

  13. Kefalopoulou Z, Tzelepi V, Zolota V, Grivas PD, Christopoulos C, Kalofonos H, et al. Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis. J Neurooncol. 2012;106(1):23–31.

    Article  CAS  PubMed  Google Scholar 

  14. Schnegg JF, Gomez F, LeMarchand-Beraud T, de Tribolet N. Presence of sex steroid hormone receptors in meningioma tissue. Surg Neurol. 1981;15(6):415–8.

    Article  CAS  PubMed  Google Scholar 

  15. Tilzer LL, Plapp FV, Evans JP, Stone D, Alward K. Steroid receptor proteins in human meningiomas. Cancer. 1982;49(4):633–6.

    Article  CAS  PubMed  Google Scholar 

  16. Lee LS, Chi CW, Chang TJ, Chou MD, Liu HC, Liu TY. Steroid hormone receptors in meningiomas of Chinese patients. Neurosurgery. 1989;25(4):541–5.

    Article  CAS  PubMed  Google Scholar 

  17. Leaes CG, Meurer RT, Coutinho LB, Ferreira NP, Pereira-Lima JF, da Costa Oliveira M. Immunohistochemical expression of aromatase and estrogen, androgen and progesterone receptors in normal and neoplastic human meningeal cells. Neuropathology. 2010;30(1):44–9.

    Article  PubMed  Google Scholar 

  18. Takei H, Buckleair LW, Powell SZ. Immunohistochemical expression of apoptosis regulating proteins and sex hormone receptors in meningiomas. Neuropathology. 2008;28(1):62–8.

    Article  PubMed  Google Scholar 

  19. Fakhrjou A, Meshkini A, Shadrvan S. Status of Ki-67, estrogen and progesterone receptors in various subtypes of intracranial meningiomas. Pak J Biol Sci. 2012;15(11):530–5.

    Article  PubMed  Google Scholar 

  20. Mancuso M, Leonardi S, Ceccarelli M, Pasquali E, De Stefano I, Prisco MG, et al. Protective role of 17 beta-estradiol on medulloblastoma development in Patched 1 heterozygous mice. Int J Cancer. 2010;127(12):2749–57.

    Article  CAS  PubMed  Google Scholar 

  21. Mancuso M, Leonardi S, Giardullo P, Pasquali E, Borra F, Stefano ID, et al. The estrogen receptor beta agonist diarylpropionitrile (DPN) inhibits medulloblastoma development via anti-proliferative and pro-apototic pathways. Cancer Lett. 2011;308(2):197–202.

    Article  CAS  PubMed  Google Scholar 

  22. Belcher SM, Ma X, Le HH. Blockade of estrogen receptor signaling inhibits growth and migration of medulloblastoma. Endocrinology. 2009;150(3):1112–21.

    Article  CAS  PubMed  Google Scholar 

  23. Bettegowda C, Agrawal N, Jiao Y, Sausen M, Wood LD, Hruban RH, et al. Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science. 2011;333(6048):1453–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Batistatou A, Kyzas PA, Goussia A, Arkoumani E, Voulgaris S, Polyzoidis K, et al. Estrogen receptor beta (ERbeta) protein expression correlates with BAG-1 and prognosis in brain glial tumours. J Neurooncol. 2006;77(1):17–23.

    Article  CAS  PubMed  Google Scholar 

  25. Batistatou A, Stefanou D, Goussia A, Arkoumani E, Papavassiliou AG, Agnantis NJ. Estrogen receptor beta (ERbeta) is expressed in brain astrocytic tumors and declines with dedifferentiation of the neoplasm. J Cancer Res Clin Oncol. 2004;130(7):405–10.

    Article  CAS  PubMed  Google Scholar 

  26. Onate SA, Tsai SY, Tsai MJ, O’Malley BW. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 1995;270(5240):1354–7.

    Article  CAS  PubMed  Google Scholar 

  27. Hong H, Kohli K, Trivedi A, Johnson DL, Stallcup MR. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc Natl Acad Sci U S A. 1996;93(10):4948–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Li H, Gomes PJ, Chen JD. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc Natl Acad Sci U S A. 1997;94(16):8479–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science. 1997;277(5328):965–8.

    Article  CAS  PubMed  Google Scholar 

  30. Nishihara E, Yoshida-Komiya H, Chan CS, Liao L, Davis RL, O’Malley BW, et al. SRC-1 null mice exhibit moderate motor dysfunction and delayed development of cerebellar Purkinje cells. J Neurosci. 2003;23(1):213–22.

    CAS  PubMed  Google Scholar 

  31. Ogawa H, Nishi M, Kawata M. Localization of nuclear coactivators p300 and steroid receptor coactivator 1 in the rat hippocampus. Brain Res. 2001;890(2):197–202.

    Article  CAS  PubMed  Google Scholar 

  32. Bian C, Zhu K, Guo Q, Xiong Y, Cai W, Zhang J. Sex differences and synchronous development of steroid receptor coactivator-1 and synaptic proteins in the hippocampus of postnatal female and male C57BL/6 mice. Steroids. 2012;77(1–2):149–56.

    Article  CAS  PubMed  Google Scholar 

  33. Zhang D, Guo Q, Bian C, Zhang J, Lin S, Su B. Alterations of steroid receptor coactivator-1 (SRC-1) immunoreactivities in specific brain regions of young and middle-aged female Sprague–Dawley rats. Brain Res. 2011;1382:88–97.

    Article  CAS  PubMed  Google Scholar 

  34. Bian C, Zhang D, Guo Q, Cai W, Zhang J. Localization and sex-difference of steroid receptor coactivator-1 immunoreactivities in the brain of adult female and male mice. Steroids. 2011;76(3):269–79.

    Article  CAS  PubMed  Google Scholar 

  35. Liu C, Zhang Y, Zhang K, Bian C, Zhao Y, Zhang J. Expression of estrogen receptors, androgen receptor and steroid receptor coactivator-3 is negatively correlated to the differentiation of astrocytic tumours. Cancer Epidemiol. 2014. doi:10.1016/ j.canep.2014.1003.1001.

    Google Scholar 

  36. Wang H, Zhang D, Wu W, Zhang J, Guo D, Wang Q, et al. Overexpression and gender-specific differences of SRC-3 (SRC-3/AIB1) immunoreactivity in human non-small cell lung cancer: an in vivo study. J Histochem Cytochem. 2010;58(12):1121–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Walsh CA, Qin L, Tien JC, Young LS, Xu J. The function of steroid receptor coactivator-1 in normal tissues and cancer. Int J Biol Sci. 2012;8(4):470–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Hernandez-Hernandez OT, Rodriguez-Dorantes M, Gonzalez-Arenas A, Camacho-Arroyo I. Progesterone and estradiol effects on SRC-1 and SRC-3 expression in human astrocytoma cell lines. Endocrine. 2010;37(1):194–200.

    Article  CAS  PubMed  Google Scholar 

  39. Gonzalez-Arenas A, Hansberg-Pastor V, Hernandez-Hernandez OT, Gonzalez-Garcia TK, Henderson-Villalpando J, Lemus-Hernandez D, et al. Estradiol increases cell growth in human astrocytoma cell lines through ERalpha activation and its interaction with SRC-1 and SRC-3 coactivators. Biochim Biophys Acta. 2012;1823(2):379–86.

    Article  CAS  PubMed  Google Scholar 

  40. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97–109.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Liu C, Zhang Y, Zhang K, Bian C, Zhao Y, Zhang J. Expression of estrogen receptors, androgen receptor and steroid receptor coactivator-3 is negatively correlated to the differentiation of astrocytic tumors. Cancer Epidemiol. 2014;38(3):291–7.

    Article  PubMed  Google Scholar 

  42. Bao X, Cao L, Piao H, Xie L. Treatment-related secondary cancer in malignant meningiomas: a population-based study. J Cancer Res Clin Oncol. 2014;140(4):583–8.

    Article  CAS  PubMed  Google Scholar 

  43. Fujimoto M, Yoshino E, Hirakawa K, Fujimoto J, Tamaya T. Estrogen receptors in brain tumors. Clin Neuropharmacol. 1984;7(4):357–62.

    Article  CAS  PubMed  Google Scholar 

  44. Tao Y, Liang G, Li Z, Wang Y, Wu A, Wang H, et al. Clinical features and immunohistochemical expression levels of androgen, estrogen, progesterone and Ki-67 receptors in relationship with gross-total resected meningiomas relapse. Br J Neurosurg. 2012;26(5):700–4.

    Article  PubMed  Google Scholar 

  45. Baxter DS, Orrego A, Rosenfeld JV, Mathiesen T. An audit of immunohistochemical marker patterns in meningioma. J Clin Neurosci. 2014;21(3):421–6.

    Article  CAS  PubMed  Google Scholar 

  46. Pencovich N, Bot G, Lidar Z, Korn A, Wostrack M, Meyer B, Bydon M, Jallo G, Constantini S. Spinal ependymoma with regional metastasis at presentation. Acta Neurochir (Wien). 2014;Mar 8. [Epub ahead of print].

  47. Deval B, Rousset P, Bigenwald C, Nogales FF, Alexandre J. Treatment of ovarian anaplastic ependymoma by an aromatase inhibitor. Obstet Gynecol. 2014;123(2 Pt 2 Suppl 2):488–91.

    Article  PubMed  Google Scholar 

  48. Stolnicu S, Furtado A, Sanches A, Nicolae A, Preda O, Hincu M, et al. Ovarian ependymomas of extra-axial type or central immunophenotypes. Hum Pathol. 2011;42(3):403–8.

    Article  CAS  PubMed  Google Scholar 

  49. Matsuyama A, Hisaoka M, Yamamoto I, Toyoshima S, Hashimoto H. Extraspinal ependymoma of the broad ligament. Pathol Int. 2010;60(3):241–4.

    Article  PubMed  Google Scholar 

  50. Concolino G, Liccardo G, Conti C, Panfili C, Giuffre R. Hormones and tumours in central nervous system (CNS): steroid receptors in primary spinal cord tumours. Neurol Res. 1984;6(3):121–6.

    Article  CAS  PubMed  Google Scholar 

  51. Favaro R, Appolloni I, Pellegatta S, Sanga AB, Pagella P, Gambini E, Pisati F, Ottolenghi S, Foti M, Finocchiaro G, Malatesta P, Nicolis SK. Sox2 is required to maintain cancer stem cells in a mouse model of high-grade oligodendroglioma. Cancer Res. 2014.

  52. Dong SM, Pang JC, Poon WS, Hu J, To KF, Chang AR, et al. Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors. J Neuropathol Exp Neurol. 2001;60(8):808–16.

    Article  CAS  PubMed  Google Scholar 

  53. Ramachandran C, Khatib Z, Petkarou A, Fort J, Fonseca HB, Melnick SJ, et al. Tamoxifen modulation of etoposide cytotoxicity involves inhibition of protein kinase C activity and insulin-like growth factor II expression in brain tumor cells. J Neurooncol. 2004;67(1–2):19–28.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant from the National Natural Science Foundation of China (No. 81171526).

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Neurobiology, Chongqing Key Laboratory of Neurobiology, Third Military Medical University, Chongqing, 400038, China

    Mengying Liu, Kaiyuan Zhang, Yangang Zhao, Qiang Guo & Jiqiang Zhang

  2. Cadet Brigade, Third Military Medical University, Chongqing, 400038, China

    Mengying Liu & Kaiyuan Zhang

  3. Institute of Pathology, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China

    Deyu Guo

Authors
  1. Mengying Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kaiyuan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yangang Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qiang Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Deyu Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jiqiang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Deyu Guo or Jiqiang Zhang.

Additional information

The Publisher and Editor retract this article in accordance with the recommendations of the Committee on Publication Ethics (COPE). After a thorough investigation we have strong reason to believe that the peer review process was compromised.

An erratum to this article is available at http://dx.doi.org/10.1007/s13277-017-5487-6.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, M., Zhang, K., Zhao, Y. et al. RETRACTED ARTICLE: Evidence for involvement of steroid receptors and coactivators in neuroepithelial and meningothelial tumors. Tumor Biol. 36, 3251–3261 (2015). https://doi.org/10.1007/s13277-014-2954-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2954-1

Keywords

Search

Navigation